Esraa K. Alhameed-Abd
Bani Suwayf, BNS, Egypt
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications
Farnesol mitigates methotrexate-induced intestinal toxicity by enhancing SIRT1, PPAR-γ, and Nrf2 signaling and attenuating Bax/cytochrome c/caspase-3-mediated apoptosis.
Journal: Immunopharmacology and immunotoxicology
Published: November 12, 2025
The promising antioxidant effects of lignans: Nrf2 activation comes into view.
Journal: Naunyn-Schmiedeberg's archives of pharmacology
Published: November 14, 2023
The enteroprotective effect of nifuroxazide against methotrexate-induced intestinal injury involves co-activation of PPAR-γ, SIRT1, Nrf2, and suppression of NF-κB and JAK1/STAT3 signals.
Journal: International immunopharmacology
Published: September 28, 2023
Pharmacological update of mirtazapine: a narrative literature review.
Journal: Naunyn-Schmiedeberg's archives of pharmacology
Published: September 07, 2023
Nrf2/HO-1 as a therapeutic target in renal fibrosis.
Journal: Life sciences
Published: August 17, 2023
Baicalin and lung diseases.
Journal: Naunyn-Schmiedeberg's archives of pharmacology
Published: May 30, 2023
Therapeutic interventions target the NLRP3 inflammasome in ulcerative colitis: Comprehensive study.
Journal: World journal of gastroenterology
Published: November 19, 2022
The molecular mechanisms underlying anti-inflammatory effects of galangin in different diseases.
Journal: Phytotherapy research : PTR
Published: November 08, 2022
Promising hepatoprotective effects of lycopene in different liver diseases.
Journal: Life sciences
Published: August 10, 2022
Pharmacological updates of nifuroxazide: Promising preclinical effects and the underlying molecular mechanisms.
Journal: European journal of pharmacology
Published: July 30, 2022
Flavonoids-mediated TLR4 Inhibition as a Promising Therapy for Renal Diseases.
Journal: Combinatorial chemistry & high throughput screening
Published: June 13, 2022
Last Updated: 09/26/2026